Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

10 January 2017 : Original article  

Re-Transplantation, Higher Creatinine Levels in Hepatitis C Virus Patients, and Donor Age Are Predictors of Mortality in Long-Term Analysis of Late Acute Rejection in Liver Transplantation

Lucas Souto Nacif1ABCDEFG*, Rafael Soares Pinheiro1ABCD, Rafael Antônio de Arruda Pécora1ABCD, Ryan Yukimatsu Tanigawa2AD, Vinicius Rocha-Santos1ABCD, Wellington Andraus1AD, Venancio Avancini Ferreira Alves2AD, Luiz Carneiro D’Albuquerque1AD

DOI: 10.12659/AOT.901010

Ann Transplant 2017; 22:9-16

Abstract

BACKGROUND: Late acute rejection (LAR) differs in its clinical and histological presentation and management from early acute rejection. This clinical entity is not completely understood; thus, we aimed to identify significant prognostic factors that can influence post-transplant survival in LAR patients. The purpose of this study was to evaluate the incidence and post-transplant survival of patients from a single center with a focus on late acute rejection.

MATERIAL AND METHODS: From January 2002 to June 2013, all liver biopsies from patients with rejection were scored using the Banff criteria. The groups were compared, and simple and multiple logistic regression and survival curves were created.

RESULTS: A total of 779 liver transplants were performed; 585 patients with no rejections and 194 patients with rejections were analyzed. The overall incidence of LAR was 6.7%, and there was a higher prevalence of early acute cellular rejection than LAR. The mean time to LAR was 564 days (median 214 days, range 91–2642). LAR had a more severe grade (35.3%) than early acute rejection (23.5%). The survival rates were similar between both modalities for the long-term period. Worse mortality rates were observed in liver re-transplantation (HR 4.77; p<0.0001); in hepatitis C virus patients with increased creatinine levels (HR 22.48; p=0.016); and in donors >41 years of age (OR 2.1; p=0.047) in a long-term analysis of LAR.

CONCLUSIONS: Liver re-transplantation, higher creatinine levels in hepatitis C virus patients, and donor age were predictors of mortality in this long-term analysis of late acute rejection in liver transplantation.

Keywords: Graft Rejection, Graft Survival, Liver Transplantation, Logistic Models

Add Comment 0 Comments

In Press

Case report  

Tongue Carcinoma in Immunosuppressed Patients After Liver and Kidney Transplantation: A Case Series

Ann Transplant In Press; DOI: 10.12659/AOT.951715  

Original article  

Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant Recipients

Ann Transplant In Press; DOI: 10.12659/AOT.952251  

Original article  

The Anatomical Landscape of Living Donor Livers: A 101-Case Retrospective Single-Center Study in Indonesia ...

Ann Transplant In Press; DOI: 10.12659/AOT.952031  

Original article  

Decreased Ventilation Duration and ICU Stay Associated With Early Percutaneous Dilatational Tracheostomy Af...

Ann Transplant In Press; DOI: 10.12659/AOT.953143  

Most Viewed Current Articles

24 Aug 2021 : Review article   20,545

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

29 Dec 2021 : Original article   16,641

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

05 Apr 2022 : Original article   15,898

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   15,796

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358